The impact of sirolimus on hepatitis C recurrence after liver transplantation

Browse by...

Deposit

Highlights

More informations

Title		The impact of sirolimus on hepatitis C recurrence after liver transplantation
Authors		Asthana, Sonal Toso, Christian Meeberg, Glenda Bigam, David L Mason, Andrew Shapiro, James Kneteman, Norman M
Published in		Canadian Journal of Gastroenterology. 2011, vol. 25, no. 1, p. 28-34
Abstract		While some immunosuppression strategies may accelerate hepatitis C virus (HCV) recurrence after liver transplantation (LT), the impact of sirolimus (SRL) is not known.
Keywords		Adult — Aged — Calcineurin/antagonists & inhibitors — Disease Progression — Female — Hepatitis C/prevention & control/surgery — Humans — Immunosuppressive Agents/therapeutic use — Kaplan-Meier Estimate — Liver Cirrhosis/surgery/virology — Liver Transplantation — Male — Middle Aged — Multivariate Analysis — Retrospective Studies — Sirolimus/therapeutic use
Identifiers		PMID: 21258665
Full text		Article (Published version) (775 Kb) - Free access Other version: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027331/
Structures		Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group		Transplantation et hépatologie (905)
Citation (ISO format)		ASTHANA, Sonal et al. The impact of sirolimus on hepatitis C recurrence after liver transplantation. In: Canadian Journal of Gastroenterology, 2011, vol. 25, n° 1, p. 28-34. https://archive-ouverte.unige.ch/unige:24903